$ASTI
Ascent Solar Technologies, Inc.

2022 Q3 Form 10-Q Financial Statement

#000156459022029327 Filed on August 12, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $6.344K $637.6K $566.2K
YoY Change -45.87% 67.57% 242.83%
Cost Of Revenue $409.8K $577.0K $532.9K
YoY Change -40.42% 36.13% 632.19%
Gross Profit -$403.5K $60.58K $33.32K
YoY Change -40.33% -239.68% -63.93%
Gross Profit Margin -6360.03% 9.5% 5.88%
Selling, General & Admin $1.890M $871.9K $821.3K
YoY Change 114.16% 8.93% 46.21%
% of Gross Profit 1439.22% 2464.78%
Research & Development $1.540M $1.453M $1.406M
YoY Change 41.75% 61.14% 93.17%
% of Gross Profit 2398.93% 4220.65%
Depreciation & Amortization $15.71K $13.05K $16.67K
YoY Change 163.68% 378.93% 29.45%
% of Gross Profit 21.54% 50.02%
Operating Expenses $3.430M $2.325M $2.228M
YoY Change 72.88% 36.59% 72.72%
Operating Profit -$7.651M -$2.282M -$2.211M
YoY Change 187.57% 29.85% 82.69%
Interest Expense -$280.1K -$32.37K -$2.086M
YoY Change -1104.84% -149.98% -168.27%
% of Operating Profit
Other Income/Expense, Net -$232.6K -$30.37K -$2.086M
YoY Change -443.84% -146.89% -168.26%
Pretax Income -$7.911M -$2.313M -$4.297M
YoY Change 208.42% 36.61% -332.74%
Income Tax
% Of Pretax Income
Net Earnings -$7.911M -$2.313M -$4.297M
YoY Change 208.41% 36.61% -332.74%
Net Earnings / Revenue -124693.66% -362.75% -758.95%
Basic Earnings Per Share -$0.24 -$0.08 -$0.20
Diluted Earnings Per Share -$0.24 -$0.08 -$0.20
COMMON SHARES
Basic Shares Outstanding 32.99M 30.59M 21.67M
Diluted Shares Outstanding 33.16M 30.59M 21.67M

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.850M $429.3K $3.028M
YoY Change -33.42% -68.38% -17.22%
Cash & Equivalents $2.850M $429.3K $3.028M
Short-Term Investments
Other Short-Term Assets $875.0K $807.5K $659.5K
YoY Change 361.2% 60.05% 509.73%
Inventory $684.4K $678.1K $637.6K
Prepaid Expenses
Receivables $112.0K $836.1K $561.3K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $4.522M $2.751M $4.887M
YoY Change -11.17% 12.21% 9.84%
LONG-TERM ASSETS
Property, Plant & Equipment $535.7K $534.7K $325.2K
YoY Change 191.43% 318.72% 1927.18%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $61.25K $91.41K $97.67K
YoY Change
Other Assets $625.0K $625.0K $625.0K
YoY Change 0.0% 0.0% 0.0%
Total Long-Term Assets $5.792M $6.001M $5.946M
YoY Change -8.83% -7.24% -8.92%
TOTAL ASSETS
Total Short-Term Assets $4.522M $2.751M $4.887M
Total Long-Term Assets $5.792M $6.001M $5.946M
Total Assets $10.31M $8.752M $10.83M
YoY Change -9.87% -1.9% -1.32%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $717.1K $827.8K $600.6K
YoY Change 10.19% 25.21% -3.54%
Accrued Expenses $2.342M $1.511M $2.552M
YoY Change 9.46% 99.81% 13.79%
Deferred Revenue
YoY Change
Short-Term Debt $250.0K $250.0K $250.0K
YoY Change -50.0% -63.94% -43.59%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $4.582M $3.836M $3.447M
YoY Change 37.38% 18.67% 3.19%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $963.2K $946.1K
YoY Change -100.0% -87.74% -88.12%
Other Long-Term Liabilities $4.026M $4.210M $4.377M
YoY Change -14.7% -13.79% -13.07%
Total Long-Term Liabilities $4.026M $5.173M $5.323M
YoY Change -68.37% -59.4% -59.04%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.582M $3.836M $3.447M
Total Long-Term Liabilities $4.026M $5.173M $5.323M
Total Liabilities $8.608M $9.009M $8.771M
YoY Change -46.41% -43.6% -46.31%
SHAREHOLDERS EQUITY
Retained Earnings -$442.3M -$434.4M
YoY Change
Common Stock $3.393K $3.059K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.706M -$257.0K $2.062M
YoY Change
Total Liabilities & Shareholders Equity $10.31M $8.752M $10.83M
YoY Change -9.87% -1.9% -1.32%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income -$7.911M -$2.313M -$4.297M
YoY Change 208.41% 36.61% -332.74%
Depreciation, Depletion And Amortization $15.71K $13.05K $16.67K
YoY Change 163.68% 378.93% 29.45%
Cash From Operating Activities -$2.550M -$2.584M -$2.792M
YoY Change 26.59% 18.17% 38.96%
INVESTING ACTIVITIES
Capital Expenditures -$28.09K -$8.600K -$57.45K
YoY Change -54.75% -92.48% 187.25%
Acquisitions
YoY Change
Other Investing Activities -$810.00 -$6.880K -$83.87K
YoY Change -575.18%
Cash From Investing Activities -$28.90K -$15.48K -$141.3K
YoY Change -53.45% -86.47% -900.76%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 5.000M 0.000 0.000
YoY Change 0.0% -100.0%
NET CHANGE
Cash From Operating Activities -2.550M -2.584M -2.792M
Cash From Investing Activities -28.90K -15.48K -141.3K
Cash From Financing Activities 5.000M 0.000 0.000
Net Change In Cash 2.421M -2.599M -2.933M
YoY Change -17.19% 12.96% -184.03%
FREE CASH FLOW
Cash From Operating Activities -$2.550M -$2.584M -$2.792M
Capital Expenditures -$28.09K -$8.600K -$57.45K
Free Cash Flow -$2.522M -$2.575M -$2.735M
YoY Change 29.18% 24.27% 37.47%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
213933
CY2022Q1 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.0002
CY2022Q1 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.0002
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
424948698
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1203781
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
545646
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2859595
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1629886
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1362126
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-2
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-2312785
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-1692939
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30587415
CY2022Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-6256
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-13353
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2319041
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1692939
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
689965
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-2
asti Warranty Reserve
WarrantyReserve
7082
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-2833606
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-4297249
CY2022Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
-7097
CY2022Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
-6256
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-256993
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-20192203
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2500000
CY2021Q1 asti Stock Issued During Period Value Of Common Stock
StockIssuedDuringPeriodValueOfCommonStock
3000000
CY2021Q1 asti Adjustments To Additional Paid In Capital Relieved On Conversion Of Derivative Liability
AdjustmentsToAdditionalPaidInCapitalRelievedOnConversionOfDerivativeLiability
1686079
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
1846384
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-5359740
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-1692939
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-7052679
us-gaap Net Income Loss
NetIncomeLoss
-6610034
us-gaap Net Income Loss
NetIncomeLoss
153445
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
34503
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
24936
asti Operating Lease Asset Amortization
OperatingLeaseAssetAmortization
340114
asti Operating Lease Asset Amortization
OperatingLeaseAssetAmortization
319468
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
2086301
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
3852140
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
786824
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-5539
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
85934
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
55029
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
559774
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
557977
asti Increase Decrease In Accounts Payable Excluding Related Party
IncreaseDecreaseInAccountsPayableExcludingRelatedParty
185596
asti Increase Decrease In Accounts Payable Excluding Related Party
IncreaseDecreaseInAccountsPayableExcludingRelatedParty
-73672
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
7127
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
-87263
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-322729
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-282680
asti Increase Decrease In Accrued Interest Payable
IncreaseDecreaseInAccruedInterestPayable
30383
asti Increase Decrease In Accrued Interest Payable
IncreaseDecreaseInAccruedInterestPayable
24909
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
305585
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-529937
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5375684
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4213354
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
83559
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
66053
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
114386
asti Proceeds From Payments To Patent Activity
ProceedsFromPaymentsToPatentActivity
-7192
asti Proceeds From Payments To Patent Activity
ProceedsFromPaymentsToPatentActivity
17648
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-156804
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-96738
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
5500000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5500000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-5532488
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1189908
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5961760
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
167725
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
429272
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1357633
asti Right Of Use Assets Acquired Through Operating Lease Liabilities
RightOfUseAssetsAcquiredThroughOperatingLeaseLiabilities
21045
us-gaap Depreciation
Depreciation
5448
asti Conversion Of Stock To Equity Amount
ConversionOfStockToEquityAmount
9200000
asti Conversion Of Stock To Equity Amount
ConversionOfStockToEquityAmount
5800000
asti Series One A Preferred Stock Conversion
SeriesOneAPreferredStockConversion
740
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
us-gaap Stockholders Equity Note Changes In Capital Structure Retroactive Impact
StockholdersEquityNoteChangesInCapitalStructureRetroactiveImpact
Following the Reverse Stock Split, the Company’s issued and outstanding shares of Common Stock were decreased from approximately 23.7 billion pre-split shares to 4.8 million post-split shares. In connection with the Reverse Stock Split effectiveness, the number of authorized shares of the Company's Common Stock were decreased from 30 billion to 500 million shares.
CY2021Q4 us-gaap Deferred Revenue
DeferredRevenue
22500
asti Additions Of Deferred Revenue
AdditionsOfDeferredRevenue
206279
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
-228669
CY2022Q2 us-gaap Deferred Revenue
DeferredRevenue
110
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2400000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2400000
CY2021Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
29100000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
29000000.0
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
534729
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
279662
CY2022Q2 us-gaap Depreciation
Depreciation
13046
CY2021Q2 us-gaap Depreciation
Depreciation
2724
us-gaap Depreciation
Depreciation
24919
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5375684
CY2022Q2 asti Working Capital Deficit
WorkingCapitalDeficit
1085161
CY2022Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
22705921
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
22425935
CY2022Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
22171192
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
22146273
asti Number Of Rentable Square Feet Of Building
NumberOfRentableSquareFeetOfBuilding
100000
us-gaap Lessee Operating Lease Description
LesseeOperatingLeaseDescription
These leases are classified and accounted for as operating leases. The building lease term is for 88 months commencing on September 21, 2020 at a rent of $50,000 per month including taxes, insurance and common area maintenance until December 31, 2020. Beginning January 1, 2021, the rent adjusted to $80,000 per month on a triple net basis and shall increase at an annual rate of 3% per annum until December 31, 2027. The Company car lease term is for 39 months commencing on June 30, 2022. The Company made a $5,000 initial payment and pays $493 per month.
CY2020Q3 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P88M
CY2020Q3 asti Lease Commencement Date
LeaseCommencementDate
2020-09-21
CY2020Q3 us-gaap Lease Cost
LeaseCost
50000
CY2021Q1 us-gaap Lease Cost
LeaseCost
80000
asti Percentage Of Rent Increase In Annual Rate
PercentageOfRentIncreaseInAnnualRate
0.03
CY2022Q2 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P39M
asti Lease Commencement Date
LeaseCommencementDate
2022-06-30
asti Lease Initial Payment
LeaseInitialPayment
5000
us-gaap Lease Cost
LeaseCost
493
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4665619
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4984688
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
689129
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
646742
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
4188419
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
4532490
CY2022Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
516785
CY2021Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
258393
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
497360
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1024381
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1054935
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1084833
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1112903
CY2022Q2 asti Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
1146290
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
5920702
CY2022Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1043154
CY2022Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
4877548
CY2022Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P66M12D
CY2022Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.070
CY2022Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
651979
CY2021Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
575154
CY2022Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
25908
CY2021Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
15803
CY2022Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
219
CY2021Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1215
CY2022Q2 us-gaap Inventory Net
InventoryNet
678106
CY2021Q4 us-gaap Inventory Net
InventoryNet
592172
CY2021Q4 asti Short Term Debt Gross
ShortTermDebtGross
10400000
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
0
asti Debt Instrument Increase Decrease Amount Redocumented Or Assigned
DebtInstrumentIncreaseDecreaseAmountRedocumentedOrAssigned
0
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
9200000
CY2022Q2 asti Short Term Debt Gross
ShortTermDebtGross
1200000
CY2022Q2 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
236852
CY2022Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
963148
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
asti Common Stock Number Of Votes Per Share
CommonStockNumberOfVotesPerShare
1
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
30587415
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
496643
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
26000
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
135050
CY2021Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
8076847
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-13353
CY2021Q4 us-gaap Standard Product Warranty Accrual Noncurrent
StandardProductWarrantyAccrualNoncurrent
21225
CY2021Q4 us-gaap Liabilities
Liabilities
15681674
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
5
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4786804
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4786804
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
479
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-427782788
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-2833606
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
12848068
CY2021Q2 asti Gain Loss On Derivative And Extinguishment Of Debt Net
GainLossOnDerivativeAndExtinguishmentOfDebtNet
234236
us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
1109885
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1693145
CY2022Q2 asti Interest Expense Excluding Warrant Liability
InterestExpenseExcludingWarrantLiability
32370
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.46
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3669117
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3669117
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-30370
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30587415
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.46
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
2062048
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-2312785

Files In Submission

Name View Source Status
0001564590-22-029327-index-headers.html Edgar Link pending
0001564590-22-029327-index.html Edgar Link pending
0001564590-22-029327.txt Edgar Link pending
0001564590-22-029327-xbrl.zip Edgar Link pending
asti-10q_20220630.htm Edgar Link pending
asti-20220630.xsd Edgar Link pending
asti-ex311_8.htm Edgar Link pending
asti-ex312_7.htm Edgar Link pending
asti-ex321_6.htm Edgar Link pending
asti-ex322_9.htm Edgar Link pending
asti-20220630_pre.xml Edgar Link unprocessable
asti-20220630_def.xml Edgar Link unprocessable
asti-20220630_cal.xml Edgar Link unprocessable
asti-10q_20220630_htm.xml Edgar Link completed
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
asti-20220630_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable